Origins and Impact of EDS in Connective Tissues and Skin
NCT ID: NCT02721797
Last Updated: 2020-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
35 participants
OBSERVATIONAL
2017-04-01
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effects of Cross Linking on the Biomechanical Characteristics of Skin Samples From Patients With Classic or Hypermobile Ehlers-Danlos Syndrome
NCT06336473
Ultrastructural Collagen Markers in Ehlers Danlos Syndromes
NCT05429996
IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients
NCT01446783
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00904163
Co-designing Digital Ulcers Opportunities With Patients and Clinicians
NCT05785403
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Skin
Patients with EDS diagnosis having surgery, have debrided skin retained for this research
Orthopaedic & Gynaecology surgery
Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.
Tendon
Patients with EDS diagnosis having surgery, have debrided tendon retained for this research
Orthopaedic & Gynaecology surgery
Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.
Uterine tissue
Patients with EDS diagnosis having surgery, have debrided uterine tissue retained for this research
Orthopaedic & Gynaecology surgery
Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.
Vaginal tissue
Patients with EDS diagnosis having surgery, have debrided vaginal tissues retained for this research
Orthopaedic & Gynaecology surgery
Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.
Ligaments
Patients with EDS diagnosis having surgery, have debrided ligaments retained for this research
Orthopaedic & Gynaecology surgery
Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Orthopaedic & Gynaecology surgery
Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with severe developmental disorders, precluding their consent for research
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College London Hospitals
OTHER
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanna Kazkaz
Role: PRINCIPAL_INVESTIGATOR
UCLH
Laurent Bozec
Role: PRINCIPAL_INVESTIGATOR
UCL
Adam Strange
Role: PRINCIPAL_INVESTIGATOR
UCL
Rodney Graham
Role: PRINCIPAL_INVESTIGATOR
UCL
Susan Parekh
Role: PRINCIPAL_INVESTIGATOR
UCLH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Collage Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15/0438
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.